> top > docs > PubMed:1482376 > annotations

PubMed:1482376 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 92-108 HP_0002721 denotes immunodeficiency
T2 161-177 HP_0002721 denotes immunodeficiency
T3 934-939 HP_0002664 denotes tumor

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 43-53 protein denotes NF-kappa B
T2 68-81 cell_type denotes human T cells
T3 195-228 DNA denotes long terminal repeat (LTR) region
T4 232-248 DNA denotes HIV proviral DNA
T5 276-298 protein denotes nuclear factor kappa B
T6 300-310 protein denotes NF-kappa B
T7 322-347 protein denotes transcriptional activator
T8 499-509 protein denotes NF-kappa B
T9 630-640 protein denotes NF-kappa B
T10 757-771 cell_line denotes Jurkat T cells
T11 901-911 protein denotes NF-kappa B
T12 934-961 protein denotes tumor necrosis factor-alpha

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-17 NP denotes Alpha-lipoic acid
C3 43-53 NP denotes NF-kappa B
C2 43-64 NP denotes NF-kappa B activation
C4 68-81 NP denotes human T cells
C5 83-124 NP denotes Acquired immunodeficiency syndrome (AIDS)
C6 153-189 NP denotes a human immunodeficiency virus (HIV)
C7 232-235 NP denotes HIV
C8 276-311 NP denotes nuclear factor kappa B (NF-kappa B)
C9 317-347 NP denotes this transcriptional activator
C10 368-371 NP denotes HIV
C11 426-455 NP denotes reactive oxygen species (ROS)
C13 499-509 NP denotes NF-kappa B
C12 499-520 NP denotes NF-kappa B activation
C14 553-560 NP denotes reports
C15 561-565 NP denotes that
C16 566-578 NP denotes antioxidants
C17 579-584 NP denotes which
C18 595-598 NP denotes ROS
C20 630-640 NP denotes NF-kappa B
C19 612-640 NP denotes the activation of NF-kappa B
C21 658-661 NP denotes HIV
C22 686-698 NP denotes antioxidants
C23 737-741 NP denotes AIDS
C24 757-771 NP denotes Jurkat T cells
C25 798-825 NP denotes a natural thiol antioxidant
C26 827-844 NP denotes alpha-lipoic acid
C28 901-911 NP denotes NF-kappa B
C27 901-1021 NP denotes NF-kappa B activation induced by tumor necrosis factor-alpha (25 ng/ml) or by phorbol 12-myristate 13-acetate (50 ng/ml)
C29 1048-1065 NP denotes alpha-lipoic acid
C30 1222-1239 NP denotes alpha-lipoic acid
C31 1260-1264 NP denotes AIDS
R1 C7 C6 coref-ident HIV,a human immunodeficiency virus (HIV)
R2 C8 C3 coref-ident nuclear factor kappa B (NF-kappa B),NF-kappa B
R3 C9 C8 coref-ident this transcriptional activator,nuclear factor kappa B (NF-kappa B)
R4 C10 C9 coref-ident HIV,this transcriptional activator
R5 C13 C8 coref-ident NF-kappa B,nuclear factor kappa B (NF-kappa B)
R6 C12 C2 coref-ident NF-kappa B activation,NF-kappa B activation
R7 C15 C14 coref-relat that,reports
R8 C17 C16 coref-relat which,antioxidants
R9 C18 C11 coref-ident ROS,reactive oxygen species (ROS)
R10 C20 C13 coref-ident NF-kappa B,NF-kappa B
R11 C19 C12 coref-ident the activation of NF-kappa B,NF-kappa B activation
R12 C21 C10 coref-ident HIV,HIV
R13 C22 C16 coref-ident antioxidants,antioxidants
R14 C23 C5 coref-ident AIDS,Acquired immunodeficiency syndrome (AIDS)
R15 C24 C4 coref-other Jurkat T cells,human T cells
R16 C25 C1 coref-other a natural thiol antioxidant,Alpha-lipoic acid
R17 C26 C25 coref-appos alpha-lipoic acid,a natural thiol antioxidant
R18 C28 C20 coref-ident NF-kappa B,NF-kappa B
R19 C27 C19 coref-ident NF-kappa B activation induced by tumor necrosis factor-alpha (25 ng/ml) or by phorbol 12-myristate 13-acetate (50 ng/ml),the activation of NF-kappa B
R20 C29 C26 coref-ident alpha-lipoic acid,alpha-lipoic acid
R21 C30 C29 coref-ident alpha-lipoic acid,alpha-lipoic acid
R22 C31 C23 coref-ident AIDS,AIDS

semrep-sample

Id Subject Object Predicate Lexical cue
E1-ti-1 0-17 cui:C0023791 denotes Alpha-lipoic acid
E2-ti-1 23-29 cui:C0237399 denotes potent
E3-ti-1 30-39 cui:C0243077 denotes inhibitor
E4-ti-1 43-53 cui:C0079904 denotes NF-kappa B
E5-ti-1 68-81 cui:C0427861 denotes human T cells
T1 54-64 STIMULATES denotes activation
E1-ab-1 83-117 cui:C0001175 denotes Acquired immunodeficiency syndrome
E2-ab-1 138-147 cui:C0021311 denotes infection
E3-ab-1 155-183 cui:C0019682 denotes human immunodeficiency virus
T2 125-132 CAUSES denotes results
E1-ab-2 195-215 cui:C0023978 denotes long terminal repeat
E2-ab-2 222-228 cui:C0205147 denotes region
E3-ab-2 232-248 cui:C0486959 denotes HIV proviral DNA
E4-ab-2 258-271 cui:C0005456 denotes binding sites
E5-ab-2 276-298 cui:C0079904 denotes nuclear factor kappa B
E6-ab-2 322-347 cui:C1336776 denotes transcriptional activator
E7-ab-2 368-371 cui:C0020114 denotes HIV
E8-ab-2 368-371 cui:C0021051 denotes HIV
E9-ab-2 368-382 cui:C0042767 denotes HIV activation
T3 359-367 AFFECTS denotes regulate
E1-ab-3 384-390 cui:C0332185 denotes Recent
E2-ab-3 391-399 cui:C0243095 denotes findings
E3-ab-3 426-449 cui:C0162772 denotes reactive oxygen species
E4-ab-3 459-487 cui:C0086982 denotes signal transduction pathways
E5-ab-3 499-509 cui:C0079904 denotes NF-kappa B
T4 510-520 STIMULATES denotes activation
E1-ab-4 526-533 cui:C0150312 denotes present
E2-ab-4 534-539 cui:C0008972 denotes study
E3-ab-4 566-578 cui:C0003402 denotes antioxidants
E4-ab-4 595-598 cui:C0162772 denotes ROS
E5-ab-4 630-640 cui:C0079904 denotes NF-kappa B
E6-ab-4 658-661 cui:C0019682 denotes HIV
E7-ab-4 662-675 cui:C0040649 denotes transcription
E8-ab-4 686-698 cui:C0003402 denotes antioxidants
E9-ab-4 714-732 cui:C1611640 denotes therapeutic agents
E10-ab-4 737-741 cui:C0001175 denotes AIDS
T5 686-732 ISA denotes antioxidants can be used as therapeutic agents
T6 686-732 ISA denotes antioxidants can be used as therapeutic agents
T7 616-626 STIMULATES denotes activation
T8 616-626 STIMULATES denotes activation
T9 733-736 TREATS denotes for
T10 686-732 TREATS denotes antioxidants can be used as therapeutic agents
T11 686-732 TREATS denotes antioxidants can be used as therapeutic agents
E1-ab-5 757-771 cui:C0376448 denotes Jurkat T cells
E2-ab-5 783-788 cui:C0007634 denotes cells
E3-ab-5 800-807 cui:C0205296 denotes natural
E4-ab-5 808-813 cui:C0038734 denotes thiol
E5-ab-5 814-825 cui:C0003402 denotes antioxidant
E6-ab-5 827-844 cui:C0023791 denotes alpha-lipoic acid
E7-ab-5 859-870 cui:C1292856 denotes stimulation
E8-ab-5 874-879 cui:C0007634 denotes cells
E9-ab-5 901-911 cui:C0079904 denotes NF-kappa B
E10-ab-5 934-961 cui:C1448177 denotes tumor necrosis factor-alpha
E11-ab-5 979-1010 cui:C0039654 denotes phorbol 12-myristate 13-acetate
T12 814-844 ISA denotes antioxidant, alpha-lipoic acid
T13 859-870 AUGMENTS denotes stimulation
T14 912-922 STIMULATES denotes activation
T15 923-930 AUGMENTS denotes induced
T16 923-930 AUGMENTS denotes induced
T17 814-844 STIMULATES denotes antioxidant, alpha-lipoic acid
E1-ab-6 1027-1037 cui:C0243077 denotes inhibitory
E2-ab-6 1048-1065 cui:C0023791 denotes alpha-lipoic acid
E3-ab-6 1082-1086 cui:C0442824 denotes very
E4-ab-6 1087-1093 cui:C0237399 denotes potent
E5-ab-6 1124-1132 cui:C0205197 denotes complete
E6-ab-6 1176-1192 cui:C0001047 denotes N-acetylcysteine
E1-ab-7 1200-1207 cui:C1274040 denotes results
E2-ab-7 1222-1239 cui:C0023791 denotes alpha-lipoic acid
E3-ab-7 1247-1256 cui:C1280500 denotes effective
E4-ab-7 1260-1264 cui:C0001175 denotes AIDS
E5-ab-7 1265-1277 cui:C0039796 denotes therapeutics
T18 1257-1259 ASSOCIATED_WITH denotes in
R1 E1-ti-1 T1 subjectOf Alpha-lipoic acid,activation
R2 E4-ti-1 T1 objectOf NF-kappa B,activation
R3 E2-ab-1 T2 subjectOf infection,results
R4 E1-ab-1 T2 objectOf Acquired immunodeficiency syndrome,results
R5 E6-ab-2 T3 subjectOf transcriptional activator,regulate
R6 E9-ab-2 T3 objectOf HIV activation,regulate
R7 E3-ab-3 T4 subjectOf reactive oxygen species,activation
R8 E5-ab-3 T4 objectOf NF-kappa B,activation
R9 E8-ab-4 T5 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R10 E9-ab-4 T5 objectOf therapeutic agents,antioxidants can be used as therapeutic agents
R11 E3-ab-4 T6 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R12 E9-ab-4 T6 objectOf therapeutic agents,antioxidants can be used as therapeutic agents
R13 E8-ab-4 T7 subjectOf antioxidants,activation
R14 E5-ab-4 T7 objectOf NF-kappa B,activation
R15 E3-ab-4 T8 subjectOf antioxidants,activation
R16 E5-ab-4 T8 objectOf NF-kappa B,activation
R17 E9-ab-4 T9 subjectOf therapeutic agents,for
R18 E10-ab-4 T9 objectOf AIDS,for
R19 E8-ab-4 T10 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R20 E10-ab-4 T10 objectOf AIDS,antioxidants can be used as therapeutic agents
R21 E3-ab-4 T11 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R22 E10-ab-4 T11 objectOf AIDS,antioxidants can be used as therapeutic agents
R23 E6-ab-5 T12 subjectOf alpha-lipoic acid,"antioxidant, alpha-lipoic acid"
R24 E5-ab-5 T12 objectOf antioxidant,"antioxidant, alpha-lipoic acid"
R25 E6-ab-5 T13 subjectOf alpha-lipoic acid,stimulation
R26 E8-ab-5 T13 objectOf cells,stimulation
R27 E5-ab-5 T14 subjectOf antioxidant,activation
R28 E9-ab-5 T14 objectOf NF-kappa B,activation
R29 E10-ab-5 T15 subjectOf tumor necrosis factor-alpha,induced
R30 E1-ab-5 T15 objectOf Jurkat T cells,induced
R31 E11-ab-5 T16 subjectOf phorbol 12-myristate 13-acetate,induced
R32 E1-ab-5 T16 objectOf Jurkat T cells,induced
R33 E6-ab-5 T17 subjectOf alpha-lipoic acid,"antioxidant, alpha-lipoic acid"
R34 E9-ab-5 T17 objectOf NF-kappa B,"antioxidant, alpha-lipoic acid"
R35 E2-ab-7 T18 subjectOf alpha-lipoic acid,in
R36 E4-ab-7 T18 objectOf AIDS,in

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-82 Sentence denotes Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells.
S2 83-190 Sentence denotes Acquired immunodeficiency syndrome (AIDS) results from infection with a human immunodeficiency virus (HIV).
S3 191-383 Sentence denotes The long terminal repeat (LTR) region of HIV proviral DNA contains binding sites for nuclear factor kappa B (NF-kappa B), and this transcriptional activator appears to regulate HIV activation.
S4 384-521 Sentence denotes Recent findings suggest an involvement of reactive oxygen species (ROS) in signal transduction pathways leading to NF-kappa B activation.
S5 522-742 Sentence denotes The present study was based on reports that antioxidants which eliminate ROS should block the activation of NF-kappa B and subsequently HIV transcription, and thus antioxidants can be used as therapeutic agents for AIDS.
S6 743-1022 Sentence denotes Incubation of Jurkat T cells (1 x 10(6) cells/ml) with a natural thiol antioxidant, alpha-lipoic acid, prior to the stimulation of cells was found to inhibit NF-kappa B activation induced by tumor necrosis factor-alpha (25 ng/ml) or by phorbol 12-myristate 13-acetate (50 ng/ml).
S7 1023-1193 Sentence denotes The inhibitory action of alpha-lipoic acid was found to be very potent as only 4 mM was needed for a complete inhibition, whereas 20 mM was required for N-acetylcysteine.
S8 1194-1278 Sentence denotes These results indicate that alpha-lipoic acid may be effective in AIDS therapeutics.

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-17 other_organic_compound denotes Alpha-lipoic acid
T2 43-53 protein_molecule denotes NF-kappa B
T3 68-81 cell_type denotes human T cells
T4 83-117 other_name denotes Acquired immunodeficiency syndrome
T5 119-123 other_name denotes AIDS
T6 155-183 virus denotes human immunodeficiency virus
T7 185-188 virus denotes HIV
T8 195-228 DNA_domain_or_region denotes long terminal repeat (LTR) region
T9 232-235 virus denotes HIV
T10 276-298 protein_molecule denotes nuclear factor kappa B
T11 300-310 protein_molecule denotes NF-kappa B
T12 322-347 protein_family_or_group denotes transcriptional activator
T13 368-371 virus denotes HIV
T14 426-449 other_organic_compound denotes reactive oxygen species
T15 451-454 other_organic_compound denotes ROS
T16 459-487 other_name denotes signal transduction pathways
T17 499-509 protein_molecule denotes NF-kappa B
T18 566-578 other_organic_compound denotes antioxidants
T19 595-598 other_organic_compound denotes ROS
T20 630-640 protein_molecule denotes NF-kappa B
T21 658-661 virus denotes HIV
T22 686-698 other_organic_compound denotes antioxidants
T23 737-741 other_name denotes AIDS
T24 757-771 cell_line denotes Jurkat T cells
T25 800-825 other_organic_compound denotes natural thiol antioxidant
T26 827-844 other_organic_compound denotes alpha-lipoic acid
T27 901-911 protein_molecule denotes NF-kappa B
T28 934-961 protein_molecule denotes tumor necrosis factor-alpha
T29 979-1010 other_organic_compound denotes phorbol 12-myristate 13-acetate
T30 1048-1065 other_organic_compound denotes alpha-lipoic acid
T31 1176-1192 amino_acid_monomer denotes N-acetylcysteine
T32 1222-1239 other_organic_compound denotes alpha-lipoic acid
T33 1260-1264 other_name denotes AIDS

metamap-sample

Id Subject Object Predicate Lexical cue
T1 1223-1240 C0023791 denotes lpha-lipoic acid
T2 1049-1066 C0023791 denotes lpha-lipoic acid
T3 828-845 C0023791 denotes lpha-lipoic acid,
T4 1-18 C0023791 denotes lpha-lipoic acid
T5 913-922 C1879547 denotes ctivation
T6 617-627 C1879547 denotes ctivation
T7 511-521 C1879547 denotes ctivation.
T8 373-383 C1879547 denotes ctivation.
T9 55-65 C1879547 denotes ctivation
T10 1088-1094 C3245505 denotes otent
T11 24-30 C3245505 denotes otent
T12 659-662 C0019682 denotes IV
T13 369-372 C0019682 denotes IV
T14 1261-1265 C0001175 denotes IDS
T15 738-742 C0001175 denotes IDS.
T16 84-118 C0001175 denotes cquired immunodeficiency syndrome
T17 902-912 C0079904 denotes F-kappa B
T18 631-641 C0079904 denotes F-kappa B
T19 500-510 C0079904 denotes F-kappa B
T20 277-299 C0079904 denotes uclear factor kappa B
T21 815-826 C0003402 denotes ntioxidant,
T22 596-599 C0162772 denotes OS
T23 427-450 C0162772 denotes eactive oxygen species
T24 935-962 C1456820 denotes umor necrosis factor-alpha
T25 1177-1193 C0001047 denotes -acetylcysteine.
T26 1077-1079 C1883351 denotes o
T27 891-893 C1883351 denotes o
T28 357-359 C1883351 denotes o
T29 663-676 C0040649 denotes ranscription,
T30 259-272 C0005456 denotes inding sites
T31 1112-1118 C0027552 denotes eeded
T32 1028-1038 C3463820 denotes nhibitory
T33 1071-1076 C0150312 denotes ound
T34 885-890 C0150312 denotes ound
T35 527-534 C0150312 denotes resent
T36 894-901 C0018790 denotes nhibit
T37 139-148 C0009450 denotes nfection
T38 809-814 C0038734 denotes hiol
T39 246-249 C0012854 denotes NA
T40 1201-1208 C2825142 denotes esults
T41 126-133 C2825142 denotes esults
T42 349-356 C0700364 denotes ppears
T43 607-612 C0332206 denotes lock
T44 875-880 C0007634 denotes ells
T45 250-258 C2700400 denotes ontains
T46 554-561 C0700287 denotes eports
T47 860-871 C1292856 denotes timulation
T48 323-348 C1336776 denotes ranscriptional activator
T49 401-408 C1705535 denotes uggest
T50 392-400 C2926606 denotes indings
T51 535-540 C2603343 denotes tudy
T52 545-550 C1705938 denotes ased
T53 715-733 C0304231 denotes herapeutic agents
T54 774-775 C2827734 denotes
T55 784-792 C2699156 denotes ells/ml)
T56 1164-1172 C1514873 denotes equired
T57 707-711 C1273517 denotes sed
T58 1125-1133 C0205197 denotes omplete
T59 1134-1144 C0021469 denotes nhibition,
T60 1248-1257 C1280519 denotes ffective
T61 924-931 C0205263 denotes nduced
T62 412-423 C1314939 denotes nvolvement
T63 1039-1045 C0441472 denotes ction
T64 489-496 C1522538 denotes eading
T65 223-229 C0205147 denotes egion
T66 385-390 C0332185 denotes ecent
T67 1083-1087 C0442824 denotes ery
T68 1098-1102 C0205171 denotes nly
T69 1266-1278 C0039796 denotes herapeutics.
T70 801-808 C0205296 denotes atural